title: Ziprasidone and psychosis in Parkinson disease.
authors.forename: Federico
authors.initials: F
authors.lastname: Micheli
authors.forename: Nora
authors.initials: N
authors.lastname: Taubenslag
authors.forename: Emilia
authors.initials: E
authors.lastname: Gatto
authors.forename: María Clara
authors.initials: MC
authors.lastname: Scorticati
mesh_terms: D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000150:complications*; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000209:etiology*; D013844:Thiazoles / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D013844:Thiazoles; C092292:ziprasidone